PutinXi Talks to Revive Power of Siberia 2 Pipeline as Energy Markets Brace for Iran Impact VERAXA Biotech Secures 275M Financing Plans Public Listing via SPAC Merger CoPays For GLP1 Weight Loss Drugs Set to Rise Amid Coverage Challenges Federal Reserve Faces Diminishing Justification for Rate Cuts as Inflation Bites ATTs BlueCollar Hiring Challenge Highlights AI Economys Shift in Workforce Demands Telsey Advisory Group Lowes Continues to Execute Amid Housing Market Weakness ESS Tech Inc GWH Q1 2026 Earnings Significant EPS Miss Amidst Revenue Disconnect Stock Gains 386 WSFS Financial Q1 2026 Earnings EPS Surpasses Estimates by 122 Stock Unchanged AZTR Q1 2026 Earnings Significant EPS Miss and Stock Decline Amid PreRevenue Stage CVV Q1 2026 Earnings Narrowing Losses as Operational Efficiencies Begin to Emerge ONIT Q1 2026 Earnings EPS Falls Short of Estimates Yet Stock Rises 139 SCLX Q1 2026 Earnings Net Loss Widens as Pipeline Progress Drives Stock Higher Mach Natural Resources MNR Faces Headwinds Down 249 as Support Levels Tested Travelzoo TZOO Edges Higher as Travel Demand Stabilizes Testing Key Resistance Abbott Laboratories ABT Edges Lower Amid Market Consolidation Key Levels in Focus American Drive Acquisition Co ADAC Holds Steady Near 994 as SPAC Investors Eye Key Levels Northann Corp NCL Edges Higher A MicroCap Stock Testing Key Resistance AIRelated Layoffs as a Stock Catalyst The Market May Not Agree Satirical Cockroach Party Reports Website Blocked Potential Free Speech and Regulatory Concerns in India AIPowered Drug Discovery Shows Potential for Brain Condition Treatments Like MND Wall Street Edges Higher as Iran Peace Talks Progress Estee Lauder and Zoom Lead Gains DA Davidson Lowers Price Target on Home Depot After Earnings Cites Macro Concerns WilliamsSonoma Stock Analysts Weigh Potential for Movement Amid Retail Shifts Europes AI Trade Dependency Could Pose Strategic Risks Report Warns RxSight Inc Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Jasper Therapeutics JSPR Edges Higher SmallCap Biotech Tests Resistance at 095